Christopher P. Klimko

573 total citations
38 papers, 370 citations indexed

About

Christopher P. Klimko is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Christopher P. Klimko has authored 38 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Epidemiology and 16 papers in Genetics. Recurrent topics in Christopher P. Klimko's work include Burkholderia infections and melioidosis (16 papers), Bacillus and Francisella bacterial research (16 papers) and Yersinia bacterium, plague, ectoparasites research (13 papers). Christopher P. Klimko is often cited by papers focused on Burkholderia infections and melioidosis (16 papers), Bacillus and Francisella bacterial research (16 papers) and Yersinia bacterium, plague, ectoparasites research (13 papers). Christopher P. Klimko collaborates with scholars based in United States, Thailand and Italy. Christopher P. Klimko's co-authors include Christopher K. Cote, Susan L. Welkos, Joel A. Bozue, Patricia L. Worsham, Jennifer L. Shoe, Kei Amemiya, David P. Fetterer, Steven J. Kern, David M. Waag and Jeremy J. Bearss and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Christopher P. Klimko

35 papers receiving 368 citations

Peers

Christopher P. Klimko
Christopher P. Klimko
Citations per year, relative to Christopher P. Klimko Christopher P. Klimko (= 1×) peers Eric Valade

Countries citing papers authored by Christopher P. Klimko

Since Specialization
Citations

This map shows the geographic impact of Christopher P. Klimko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Klimko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Klimko more than expected).

Fields of papers citing papers by Christopher P. Klimko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Klimko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Klimko. The network helps show where Christopher P. Klimko may publish in the future.

Co-authorship network of co-authors of Christopher P. Klimko

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Klimko. A scholar is included among the top collaborators of Christopher P. Klimko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Klimko. Christopher P. Klimko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Meinig, J. Matthew, Robert P. Edwards, Christopher P. Klimko, et al.. (2025). Implementation of a post-exposure tularemia treatment model for pneumonic challenged Fischer rats. Microbial Pathogenesis. 208. 107981–107981.
3.
Cote, Christopher K., Christopher P. Klimko, Michael L. Davies, et al.. (2025). Comparison of homologous and heterologous vaccination strategies for combating disease caused by Burkholderia pseudomallei. Frontiers in Immunology. 16. 1596265–1596265.
4.
Davies, Michael L., Christopher P. Klimko, Jeremy A. Miller, et al.. (2024). Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague. Frontiers in Immunology. 15. 1397579–1397579. 6 indexed citations
5.
McCurdy, Sandra P., et al.. (2023). Efficacy of delafloxacin against the biothreat pathogenBacillus anthracis. Journal of Antimicrobial Chemotherapy. 78(3). 810–816. 4 indexed citations
6.
Klimko, Christopher P., Jennifer L. Shoe, Michael L. Davies, et al.. (2023). Live attenuated vaccines and layered defense strategies to combat infections caused by nonencapsulated Yersinia pestis. 2. 4 indexed citations
7.
Klimko, Christopher P., Jennifer L. Shoe, Marcellene A. Gates‐Hollingsworth, et al.. (2023). Functional assays to screen and select monoclonal antibodies that target Yersinia pestis. Human Vaccines & Immunotherapeutics. 19(2). 2216085–2216085. 4 indexed citations
8.
Richardson, Joshua B., Christopher P. Klimko, David P. Fetterer, et al.. (2021). Development, Phenotypic Characterization and Genomic Analysis of a Francisella tularensis Panel for Tularemia Vaccine Testing. Frontiers in Microbiology. 12. 725776–725776. 6 indexed citations
9.
Fetterer, David P., Christopher P. Klimko, Jo Lynne Raymond, et al.. (2021). Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model. PLoS neglected tropical diseases. 15(2). e0009125–e0009125. 10 indexed citations
10.
González, Luis O., Christopher P. Klimko, Jennifer L. Shoe, et al.. (2020). Anthrax toxin component, Protective Antigen, protects insects from bacterial infections. PLoS Pathogens. 16(8). e1008836–e1008836. 8 indexed citations
11.
Cote, Christopher K., et al.. (2020). Combinations of early generation antibiotics and antimicrobial peptides are effective against a broad spectrum of bacterial biothreat agents. Microbial Pathogenesis. 142. 104050–104050. 25 indexed citations
12.
Biot, Fabrice, G. I. Koroleva, Sean Lovett, et al.. (2020). Evolution of Antibiotic Resistance in Surrogates of Francisella tularensis (LVS and Francisella novicida): Effects on Biofilm Formation and Fitness. Frontiers in Microbiology. 11. 593542–593542. 21 indexed citations
13.
Chua, Jennifer, Christopher K. Cote, Christopher P. Klimko, et al.. (2019). A Francisella novicida Mutant, Lacking the Soluble Lytic Transglycosylase Slt, Exhibits Defects in Both Growth and Virulence. Frontiers in Microbiology. 10. 1343–1343. 10 indexed citations
14.
Plaut, Roger D., Mark A. Munson, Christopher P. Klimko, et al.. (2018). AvirulentBacillus anthracisStrain with Molecular Assay Targets as Surrogate for Irradiation-Inactivated Virulent Spores. Emerging infectious diseases. 24(4). 1 indexed citations
15.
Shea, April A., Christopher K. Cote, Jeffrey W. Koehler, et al.. (2017). Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences. PLoS ONE. 12(2). e0171363–e0171363. 9 indexed citations
16.
Bearss, Jeremy J., Christopher P. Klimko, Jennifer L. Shoe, et al.. (2017). Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice. PLoS ONE. 12(2). e0172627–e0172627. 26 indexed citations
17.
Bozue, Joel A., Sidhartha Chaudhury, Kei Amemiya, et al.. (2016). Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice. Frontiers in Cellular and Infection Microbiology. 6. 21–21. 12 indexed citations
18.
Cote, Christopher K., Kei Amemiya, David M. Waag, et al.. (2016). Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice. Archives of Microbiology. 199(2). 277–301. 12 indexed citations
19.
Welkos, Susan L., Christopher P. Klimko, Steven J. Kern, et al.. (2015). Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays. PLoS ONE. 10(4). e0124667–e0124667. 45 indexed citations
20.
Challacombe, Jean F., Chris Stubben, Christopher P. Klimko, et al.. (2014). Interrogation of the Burkholderia pseudomallei Genome to Address Differential Virulence among Isolates. PLoS ONE. 9(12). e115951–e115951. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026